Advertisement
<< Back To Article
Gilead's HIV 'Quad' Tablet Now Before FDA for Approval Review

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*

3 Comments

shplerg

Two successful 48-week Phase III trials should be enough. How long between submission and approval? And then how long between approval and availability? Are they permitted to start production in advance to address pent-up demand?

December 20, 2011 Metropolis

Phoenix Rising

I'm sure our insurance companies won't cover it, just like most of them won't cover atripla.

November 14, 2011 Phoenix

JDCarss

Ya right like the FDA is really in any hurry to help people with HIV. Its all hypocrisy. The FDA isn't fooling anyone.

November 2, 2011 Phoenix

Advertisement

Hot topics


POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.